Catalyst Wire Dossier Catalyst Wire Dossier

BENICAR HCT

olmesartan medoxomil-hydrochlorothiazide · Cosette Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for BENICAR HCT, covering 2007-11-16 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control [Phase 3]

See pricing